{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T14:13:57Z","timestamp":1742912037120,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":48,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071642634"},{"type":"electronic","value":"9781071642641"}],"license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4264-1_9","type":"book-chapter","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T13:33:24Z","timestamp":1731677604000},"page":"163-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Creating Physiological Cell Environments In Vitro: Adjusting Cell Culture Media Composition and Oxygen Levels to Investigate Mitochondrial Function and Cancer Metabolism"],"prefix":"10.1007","author":[{"given":"S\u00f3nia A.","family":"Pinho","sequence":"first","affiliation":[]},{"given":"Georgina L.","family":"Gardner","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Alva","sequence":"additional","affiliation":[]},{"given":"Jeff A.","family":"Stuart","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7382-0339","authenticated-orcid":false,"given":"Teresa","family":"Cunha-Oliveira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3389\/fphar.2019.01484","volume":"10","author":"C Hirsch","year":"2019","unstructured":"Hirsch C, Schildknecht S (2019) In vitro research reproducibility: keeping up high standards. Front Pharmacol 10:1484. https:\/\/doi.org\/10.3389\/fphar.2019.01484","journal-title":"Front Pharmacol"},{"issue":"1","key":"9_CR2","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corro","year":"2020","unstructured":"Corro C, Novellasdemunt L, Li VSW (2020) A brief history of organoids. Am J Physiol Cell Physiol 319(1):C151\u2013CC65. https:\/\/doi.org\/10.1152\/ajpcell.00120.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"9_CR3","doi-asserted-by":"publisher","unstructured":"Group TRw (2023) Reporting in vitro experiments responsibly\u2014the RIVER recommendations. MetaArXiv https:\/\/doi.org\/10.31222\/osf.io\/x6aut","DOI":"10.31222\/osf.io\/x6aut"},{"issue":"1","key":"9_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0250-474X.89750","volume":"73","author":"T Arora","year":"2011","unstructured":"Arora T, Mehta AK, Joshi V, Mehta KD, Rathor N, Mediratta PK et al (2011) Substitute of animals in drug research: an approach towards fulfillment of 4R\u2019s. Indian J Pharm Sci 73(1):1\u20136. https:\/\/doi.org\/10.4103\/0250-474X.89750","journal-title":"Indian J Pharm Sci"},{"issue":"4","key":"9_CR5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/biomedicines11041058","volume":"11","author":"EM Tosca","year":"2023","unstructured":"Tosca EM, Ronchi D, Facciolo D, Magni P (2023) Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3d in vitro cancer models in the drug efficacy assessment. Biomedicines 11(4):1058. https:\/\/doi.org\/10.3390\/biomedicines11041058","journal-title":"Biomedicines"},{"issue":"5","key":"9_CR6","doi-asserted-by":"publisher","first-page":"dev156166","DOI":"10.1242\/dev.156166","volume":"145","author":"C Liu","year":"2018","unstructured":"Liu C, Oikonomopoulos A, Sayed N, Wu JC (2018) Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond. Development 145(5):dev156166. https:\/\/doi.org\/10.1242\/dev.156166","journal-title":"Development"},{"issue":"10","key":"9_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","volume":"21","author":"J Kim","year":"2020","unstructured":"Kim J, Koo BK, Knoblich JA (2020) Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 21(10):571\u2013584. https:\/\/doi.org\/10.1038\/s41580-020-0259-3","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9_CR8","doi-asserted-by":"publisher","unstructured":"Loewa A, Feng JJ, Hedtrich S (2023) Human disease models in drug development. Nat Rev Bioeng. https:\/\/doi.org\/10.1038\/s44222-023-00063-3","DOI":"10.1038\/s44222-023-00063-3"},{"issue":"8","key":"9_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/oxfordjournals.humrep.a136473","volume":"1","author":"RM Pearson","year":"1986","unstructured":"Pearson RM (1986) In-vitro techniques: can they replace animal testing? Hum Reprod 1(8):559\u2013560. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a136473","journal-title":"Hum Reprod"},{"issue":"3","key":"9_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/bioengineering7030115","volume":"7","author":"P Bedard","year":"2020","unstructured":"Bedard P, Gauvin S, Ferland K, Caneparo C, Pellerin E, Chabaud S et al (2020) Innovative human three-dimensional tissue-engineered models as an alternative to animal testing. Bioengineering (Basel) 7(3):115. https:\/\/doi.org\/10.3390\/bioengineering7030115","journal-title":"Bioengineering (Basel)"},{"key":"9_CR11","doi-asserted-by":"publisher","unstructured":"Saeidnia S, Manayi A, Abdollahi M (2015) From in vitro experiments to in vivo and clinical studies. Pros and Cons Curr Drug Discov Technol 12(4):218\u201324 doi: https:\/\/doi.org\/10.2174\/1570163813666160114093140.","DOI":"10.2174\/1570163813666160114093140"},{"issue":"4","key":"9_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/aivt.2016.0026","volume":"4","author":"T Hartung","year":"2018","unstructured":"Hartung T (2018) Perspectives on in vitro to in vivo extrapolations. Appl In Vitro Toxicol 4(4):305\u2013316. https:\/\/doi.org\/10.1089\/aivt.2016.0026","journal-title":"Appl In Vitro Toxicol"},{"key":"9_CR13","doi-asserted-by":"publisher","unstructured":"Herrera C (2019) The pre-clinical toolbox of pharmacokinetics and pharmacodynamics: in vitro and ex vivo models. Front Pharmacol 10(578). https:\/\/doi.org\/10.3389\/fphar.2019.00578","DOI":"10.3389\/fphar.2019.00578"},{"issue":"1","key":"9_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12018-008-9008-4","volume":"6","author":"E Mini","year":"2009","unstructured":"Mini E, Nobili S (2009) Pharmacogenetics: implementing personalized medicine. Clin Cases Miner Bone Metab 6(1):17\u201323. https:\/\/doi.org\/10.1007\/s12018-008-9008-4","journal-title":"Clin Cases Miner Bone Metab"},{"issue":"4","key":"9_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/clpt.2012.125","volume":"92","author":"JA Johnson","year":"2012","unstructured":"Johnson JA, Burkley BM, Langaee TY, Clare-Salzler MJ, Klein TE, Altman RB (2012) Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array. Clin Pharmacol Ther 92(4):437\u2013439. https:\/\/doi.org\/10.1038\/clpt.2012.125","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/2472555219897270","volume":"25","author":"J Maynard","year":"2020","unstructured":"Maynard J, Hart P (2020) The opportunities and use of imaging to measure target engagement. SLAS Discovery 25(2):127\u2013136. https:\/\/doi.org\/10.1177\/2472555219897270","journal-title":"SLAS Discovery"},{"issue":"Supplement_5","key":"9_CR17","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/neuonc\/noab183","volume":"23","author":"AKS Arakaki","year":"2021","unstructured":"Arakaki AKS, Szulzewsky F, Gilbert MR, Gujral TS, Holland EC (2021) Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers. Neuro-Oncology 23(Supplement_5):S4\u2013S15. https:\/\/doi.org\/10.1093\/neuonc\/noab183","journal-title":"Neuro-Oncology"},{"key":"9_CR18","doi-asserted-by":"publisher","unstructured":"Madelaire CB, Klink AC, Israelsen WJ, Hindle AG (2022) Fibroblasts as an experimental model system for the study of comparative physiology. Comp Biochem Physiol B Biochem Mol Biol 260. https:\/\/doi.org\/10.1016\/j.cbpb.2022.110735","DOI":"10.1016\/j.cbpb.2022.110735"},{"key":"9_CR19","doi-asserted-by":"publisher","unstructured":"Juhl P, Bondesen S, Hawkins CL, Karsdal MA, Bay-Jensen A-C, Davies MJ et al (2020) Dermal fibroblasts have different extracellular matrix profiles induced by TGF-\u03b2, PDGF and IL-6 in a model for skin fibrosis. Sci Rep 10(1). https:\/\/doi.org\/10.1038\/s41598-020-74179-6","DOI":"10.1038\/s41598-020-74179-6"},{"issue":"4","key":"9_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2174\/1570159X17666191021141057","volume":"18","author":"P Mesdom","year":"2020","unstructured":"Mesdom P, Colle R, Lebigot E, Trabado S, Deflesselle E, Feve B et al (2020) Human dermal fibroblast: a promising cellular model to study biological mechanisms of major depression and antidepressant drug response. Curr Neuropharmacol 18(4):301\u2013318. https:\/\/doi.org\/10.2174\/1570159X17666191021141057","journal-title":"Curr Neuropharmacol"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.neuroscience.2016.01.067","volume":"320","author":"S K\u00e1lm\u00e1n","year":"2016","unstructured":"K\u00e1lm\u00e1n S, Garbett KA, Janka Z, Mirnics K (2016) Human dermal fibroblasts in psychiatry research. Neuroscience 320:105\u2013121. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.01.067","journal-title":"Neuroscience"},{"key":"9_CR22","doi-asserted-by":"publisher","unstructured":"Deus CM, Pereira SP, Cunha-Oliveira T, Pereira FB, Raimundo N, Oliveira PJ (2020) Mitochondrial remodeling in human skin fibroblasts from sporadic male Parkinson\u2019s disease patients uncovers metabolic and mitochondrial bioenergetic defects. Biochim Biophys Acta (BBA) Mol Basis Dis 1866(3). https:\/\/doi.org\/10.1016\/j.bbadis.2019.165615","DOI":"10.1016\/j.bbadis.2019.165615"},{"key":"9_CR23","doi-asserted-by":"publisher","unstructured":"Tokuyama T, Hirai A, Shiiba I, Ito N, Matsuno K, Takeda K et al (2020) Mitochondrial dynamics regulation in skin fibroblasts from mitochondrial disease patients. Biomolecules 10(3). https:\/\/doi.org\/10.3390\/biom10030450","DOI":"10.3390\/biom10030450"},{"key":"9_CR24","doi-asserted-by":"publisher","unstructured":"Oblong JE, Bowman A, Rovito HA, Jarrold BB, Sherrill JD, Black MR et al (2020) Metabolic dysfunction in human skin: restoration of mitochondrial integrity and metabolic output by nicotinamide (niacinamide) in primary dermal fibroblasts from older aged donors. Aging Cell 19(10). https:\/\/doi.org\/10.1111\/acel.13248","DOI":"10.1111\/acel.13248"},{"issue":"1","key":"9_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/toxsci\/kfy068","volume":"164","author":"SP Pereira","year":"2018","unstructured":"Pereira SP, Deus CM, Serafim TL, Cunha-Oliveira T, Oliveira PJ (2018) Metabolic and phenotypic characterization of human skin fibroblasts after forcing oxidative capacity. Toxicol Sci 164(1):191\u2013204. https:\/\/doi.org\/10.1093\/toxsci\/kfy068","journal-title":"Toxicol Sci"},{"issue":"17","key":"9_CR26","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1111\/febs.16413","volume":"289","author":"SA Pinho","year":"2022","unstructured":"Pinho SA, Costa CF, Deus CM, Pinho SLC, Miranda-Santos I, Afonso G et al (2022) Mitochondrial and metabolic remodelling in human skin fibroblasts in response to glucose availability. The FEBS J 289(17):5198\u20135217. https:\/\/doi.org\/10.1111\/febs.16413","journal-title":"The FEBS J"},{"key":"9_CR27","doi-asserted-by":"publisher","unstructured":"Olesen MA, Villavicencio-Tejo F, Quintanilla RA (2022) The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. Translational. Neurodegeneration 11(1). https:\/\/doi.org\/10.1186\/s40035-022-00308-y","DOI":"10.1186\/s40035-022-00308-y"},{"issue":"5","key":"9_CR28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.avsg.2009.03.007","volume":"23","author":"LK Karlsson","year":"2009","unstructured":"Karlsson LK, Junker JPE, Greneg\u00e5rd M, Kratz G (2009) Human dermal fibroblasts: a potential cell source for endothelialization of vascular grafts. Ann Vasc Surg 23(5):663\u2013674. https:\/\/doi.org\/10.1016\/j.avsg.2009.03.007","journal-title":"Ann Vasc Surg"},{"key":"9_CR29","doi-asserted-by":"publisher","unstructured":"Pinho SA, Anjo SI, Cunha-Oliveira T (2023) Metabolic priming as a tool in redox and mitochondrial theragnostics. Antioxidants (Basel) 12(5). https:\/\/doi.org\/10.3390\/antiox12051072","DOI":"10.3390\/antiox12051072"},{"key":"9_CR30","doi-asserted-by":"publisher","unstructured":"Dzobo K, Dandara C (2023) The extracellular matrix: its composition, function, remodeling, and role in tumorigenesis. Biomimetics 8(2). https:\/\/doi.org\/10.3390\/biomimetics8020146","DOI":"10.3390\/biomimetics8020146"},{"issue":"2","key":"9_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/toxsci\/kfm052","volume":"97","author":"LD Marroquin","year":"2007","unstructured":"Marroquin LD, Hynes J, Dykens JA, Jamieson JD, Will Y (2007) Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants. Toxicol Sci 97(2):539\u2013547. https:\/\/doi.org\/10.1093\/toxsci\/kfm052","journal-title":"Toxicol Sci"},{"issue":"5","key":"9_CR32","doi-asserted-by":"publisher","first-page":"C778","DOI":"10.1152\/ajpcell.00460.2020","volume":"320","author":"RA Skolik","year":"2021","unstructured":"Skolik RA, Solocinski J, Konkle ME, Chakraborty N, Menze MA (2021) Global changes to HepG2 cell metabolism in response to galactose treatment. Am J Physiol Cell Physiol 320(5):C778\u2013CC93. https:\/\/doi.org\/10.1152\/ajpcell.00460.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"9_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/B978-0-323-88462-4.00002-X","volume-title":"Mitochondrial Intoxication","author":"GJM Afonso","year":"2023","unstructured":"Afonso GJM, Sim\u00f5es RF, Pinho SLC, Oliveira PJ, Cunha-Oliveira T (2023) Challenges in mitochondrial profiling during pre-clinical studies. In: Mitochondrial Intoxication, pp 101\u2013131"},{"key":"9_CR34","doi-asserted-by":"publisher","unstructured":"Alva R, Gardner GL, Liang P, Stuart JA (2022) Supraphysiological oxygen levels in mammalian cell culture: current state and future perspectives. Cells 11(19). https:\/\/doi.org\/10.3390\/cells11193123","DOI":"10.3390\/cells11193123"},{"issue":"5","key":"9_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1134\/S0026893322050077","volume":"56","author":"MV Golikov","year":"2022","unstructured":"Golikov MV, Valuev-Elliston VT, Smirnova OA, Ivanov AV (2022) Physiological media in studies of cell metabolism. Mol Biol 56(5):629\u2013637. https:\/\/doi.org\/10.1134\/S0026893322050077","journal-title":"Mol Biol"},{"issue":"1","key":"9_CR36","doi-asserted-by":"publisher","first-page":"eaau7314","DOI":"10.1126\/sciadv.aau7314","volume":"5","author":"J Vande Voorde","year":"2019","unstructured":"Vande Voorde J, Ackermann T, Pfetzer N, Sumpton D, Mackay G, Kalna G et al (2019) Improving the metabolic fidelity of cancer models with a physiological cell culture medium. Sci Adv 5(1):eaau7314. https:\/\/doi.org\/10.1126\/sciadv.aau7314","journal-title":"Sci Adv"},{"issue":"2","key":"9_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","volume":"169","author":"JR Cantor","year":"2017","unstructured":"Cantor JR, Abu-Remaileh M, Kanarek N, Freinkman E, Gao X, Louissaint A Jr et al (2017) Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 169(2):258\u201372 e17. https:\/\/doi.org\/10.1016\/j.cell.2017.03.023","journal-title":"Cell"},{"issue":"6392","key":"9_CR38","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1126\/science.aar5986","volume":"360","author":"A Muir","year":"2018","unstructured":"Muir A, Vander Heiden MG (2018) The nutrient environment affects therapy. Science 360(6392):962\u2013963. https:\/\/doi.org\/10.1126\/science.aar5986","journal-title":"Science"},{"issue":"1035","key":"9_CR39","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR (2014) Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol 87(1035):20130676. https:\/\/doi.org\/10.1259\/bjr.20130676","journal-title":"Br J Radiol"},{"key":"9_CR40","first-page":"10.3390\/biom121","volume":"12(11):doi","author":"R Alva","year":"2022","unstructured":"Alva R, Moradi F, Liang P, Stuart JA (2022) Culture of cancer cells at physiological oxygen levels affects gene expression in a cell-type specific manner. Biomolecules 12(11):doi:10.3390\/biom12111684","journal-title":"Biomolecules"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.freeradbiomed.2017.10.003","volume":"113","author":"TL Place","year":"2017","unstructured":"Place TL, Domann FE, Case AJ (2017) Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research. Free Radic Biol Med 113:311\u2013322. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.10.003","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"9_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204269","volume":"13","author":"A Al-Ani","year":"2018","unstructured":"Al-Ani A, Toms D, Kondro D, Thundathil J, Yu Y, Ungrin M (2018) Oxygenation in cell culture: critical parameters for reproducibility are routinely not reported. PLoS One 13(10):e0204269. https:\/\/doi.org\/10.1371\/journal.pone.0204269","journal-title":"PLoS One"},{"issue":"1","key":"9_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1152\/physrev.00041.2017","volume":"99","author":"TP Keeley","year":"2019","unstructured":"Keeley TP, Mann GE (2019) Defining physiological normoxia for improved translation of cell physiology to animal models and humans. Physiol Rev. 99(1):161\u2013234. https:\/\/doi.org\/10.1152\/physrev.00041.2017","journal-title":"Physiol Rev."},{"issue":"3","key":"9_CR44","doi-asserted-by":"publisher","first-page":"C823","DOI":"10.1152\/ajpcell.00403.2021","volume":"323","author":"GL Gardner","year":"2022","unstructured":"Gardner GL, Moradi F, Moffatt C, Cliche M, Garlisi B, Gratton J et al (2022) Rapid nutrient depletion to below the physiological range by cancer cells cultured in Plasmax. Am J Physiol Cell Physiol 323(3):C823\u2013CC34. https:\/\/doi.org\/10.1152\/ajpcell.00403.2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"9_CR45","doi-asserted-by":"publisher","unstructured":"Sullivan MR, Danai LV, Lewis CA, Chan SH, Gui DY, Kunchok T et al (2019) Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8. https:\/\/doi.org\/10.7554\/eLife.44235","DOI":"10.7554\/eLife.44235"},{"issue":"1","key":"9_CR46","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A (2021) CellProfiler 4: improvements in speed, utility and usability. BMC Bioinf 22(1):433. https:\/\/doi.org\/10.1186\/s12859-021-04344-9","journal-title":"BMC Bioinf"},{"issue":"15","key":"9_CR47","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14541","volume":"8","author":"HM Swartz","year":"2020","unstructured":"Swartz HM, Flood AB, Schaner PE, Halpern H, Williams BB, Pogue BW et al (2020) How best to interpret measures of levels of oxygen in tissues to make them effective clinical tools for care of patients with cancer and other oxygen-dependent pathologies. Physiol Rep 8(15):e14541. https:\/\/doi.org\/10.14814\/phy2.14541","journal-title":"Physiol Rep"},{"issue":"4","key":"9_CR48","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0360-3016(00)00803-8","volume":"48","author":"AC Koong","year":"2000","unstructured":"Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM et al (2000) Pancreatic tumors show high levels of hypoxia. Int J Radiat Oncol Biol Phys 48(4):919\u2013922. https:\/\/doi.org\/10.1016\/s0360-3016(00)00803-8","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Methods in Molecular Biology","Mitochondrial Bioenergetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4264-1_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T19:14:47Z","timestamp":1737486887000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4264-1_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"ISBN":["9781071642634","9781071642641"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4264-1_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"16 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}